Literature DB >> 16941462

Jaw tremor: prevalence and clinical correlates in three essential tremor case samples.

Elan D Louis1, Eileen Rios, Lakeisha M Applegate, Nora C Hernandez, Howard F Andrews.   

Abstract

The spectrum of involuntary movements seen in essential tremor (ET) is limited. Jaw tremor is one such movement. The prevalence and clinical correlates of jaw tremor have not been studied in detail. The objective of this study was to estimate the prevalence and examine the clinical correlates of jaw tremor in ET using ET cases from three distinct settings (population, tertiary-referral center, brain repository). All ET cases underwent a videotaped tremor examination in which tremors (including limb, head, voice, and jaw) were assessed. The prevalence [95% confidence interval (CI)] of jaw tremor was lowest in the population sample (7.5%; 3.9%-14.2%), intermediate in the tertiary-referral center (10.1%; 6.8%-14.7%), and highest in the brain repository (18.0%; 12.3%-25.5%; P = 0.03). Jaw tremor was associated with older age (P < 0.001), more severe action tremor of the arms (P < 0.001), and presence of head and voice tremor (P < 0.001). Jaw tremor was present in 4/14 (28.6%) ET cases with consistent rest tremor vs. 15/193 (7.8%) cases without rest tremor (odds ratio = 4.8; 95% CI = 1.3-7.0; P = 0.009). The prevalence of jaw tremor was 7.5% to 18.0% and was dependent on the mode of ascertainment, being least prevalent in a population-based sample. ET cases with jaw tremor had a more clinically severe and more topographically widespread disorder. The association in our study between jaw tremor and rest tremor, along with the published observation that jaw tremor can occur in Parkinson's disease (PD), raises the question whether jaw tremor in ET is a marker for subsequent conversion to PD.

Entities:  

Mesh:

Year:  2006        PMID: 16941462     DOI: 10.1002/mds.21069

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  24 in total

1.  Utility of the hand-drawn spiral as a tool in clinical-epidemiological research on essential tremor: data from four essential tremor cohorts.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2015-02-17       Impact factor: 3.282

Review 2.  Challenges in essential tremor genetics.

Authors:  L N Clark; E D Louis
Journal:  Rev Neurol (Paris)       Date:  2015-05-21       Impact factor: 2.607

3.  Tandem gait performance in essential tremor: clinical correlates and association with midline tremors.

Authors:  Elan D Louis; Eileen Rios; Ashwini K Rao
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

Review 4.  Essential tremor: from bedside to bench and back to bedside.

Authors:  Elan D Louis
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

Review 5.  'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2013-12-03       Impact factor: 3.282

6.  Facial tremors in patients with and without parkinsonism.

Authors:  Malco Rossi; Miguel Wilken; Pierre Morisset; Sofia Fariña; Daniel Cerquetti; Marcelo Merello
Journal:  Neurol Sci       Date:  2016-07-28       Impact factor: 3.307

7.  Torpedoes in the cerebellar vermis in essential tremor cases vs. controls.

Authors:  Elan D Louis; Phyllis L Faust; Karen J Ma; Mia Yu; Etty Cortes; Jean-Paul G Vonsattel
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

8.  Familial aggregation of cranial tremor in familial essential tremor.

Authors:  Elan D Louis; Nora Hernandez; Lorraine N Clark; Ruth Ottman
Journal:  Neuroepidemiology       Date:  2013-05-25       Impact factor: 3.282

Review 9.  Understanding essential tremor: progress on the biological front.

Authors:  Elan D Louis
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

10.  How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings.

Authors:  E D Louis; E Rios; C Henchcliffe
Journal:  Eur J Neurol       Date:  2010-01-07       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.